Literature DB >> 29682114

Infrainguinal Lesion of Peripheral Artery Disease and Levels of ω-3 Polyunsaturated Fatty Acids in Peripheral Artery Disease.

Tomoaki Iwasaki1, Toshiya Nishibe1, Yumiko Ohya2, Shigeru Inoue2, Hitoshi Ogino1.   

Abstract

Background: Recently, reduced serum levels of ω-3 polyunsaturated fatty acids (PUFAs) including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), have been focused upon as newly recognized risk factors for peripheral artery disease (PAD). The present study investigated the association between disease location and serum levels of ω-3 PUFAs in patients with PAD.
Methods: We retrospectively analyzed the data of patients at Tokyo Medical University between August 2011 and November 2015. The subjects included 98 patients who were categorized into two groups: those with (n=72) and without infrainguinal lesions (n=26).
Results: Univariate analysis revealed that low ankle-brachial pressure index (ABI) values, low EPA levels, low DHA levels, low triglyceride levels, and diabetes mellitus were significant risk factors for infrainguinal lesions. Multivariate analysis indicated that low ABI values [p=0.018; odds ratio, 0.043; 95% confidence interval (CI), 0.003-0.579] and low DHA levels (p=0.003; odds ratio, 0.986; 95%CI, 0.977-0.995) were significant independent risk factors for infrainguinal lesions.
Conclusion: Our study demonstrated that reduced serum level of DHA may underlie the presence of infrainguinal lesions in patients with PAD.

Entities:  

Keywords:  docosahexaenoic acid; lower extremities; peripheral artery disease; ω-3 polyunsaturated fatty acids

Year:  2018        PMID: 29682114      PMCID: PMC5882348          DOI: 10.3400/avd.oa.17-00085

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  25 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Relationships between plasma fatty acid composition and coronary artery disease.

Authors:  Hiroshige Itakura; Mitsuhiro Yokoyama; Masunori Matsuzaki; Yasushi Saito; Hideki Origasa; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2010-11-17       Impact factor: 4.928

3.  Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.

Authors:  Richard J Woodman; Trevor A Mori; Valerie Burke; Ian B Puddey; Anne Barden; Gerald F Watts; Lawrence J Beilin
Journal:  Atherosclerosis       Date:  2003-01       Impact factor: 5.162

4.  Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease.

Authors:  Masahiko Fujihara; Mitsuhiro Fukata; Keita Odashiro; Toru Maruyama; Koichi Akashi; Yoshiaki Yokoi
Journal:  Angiology       Date:  2012-02-26       Impact factor: 3.619

5.  Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease.

Authors:  Yuichi Ishikawa; Mitsuhiro Yokoyama; Yasushi Saito; Masunori Matsuzaki; Hideki Origasa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato; Yuji Matsuzawa
Journal:  Circ J       Date:  2010-05-18       Impact factor: 2.993

6.  Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

Authors:  Abbie L Cawood; Ren Ding; Frances L Napper; Ruth H Young; Jennifer A Williams; Matthew J A Ward; Ola Gudmundsen; Runar Vige; Simon P K Payne; Shu Ye; Ciff P Shearman; Patrick J Gallagher; Robert F Grimble; Philip C Calder
Journal:  Atherosclerosis       Date:  2010-05-20       Impact factor: 5.162

7.  Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD.

Authors:  Arja T Erkkilä; Nirupa R Matthan; David M Herrington; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2006-09-18       Impact factor: 5.922

8.  Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.

Authors:  H C McGill; C A McMahan; E E Herderick; R E Tracy; G T Malcom; A W Zieske; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

9.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.

Authors:  Masayuki Ueeda; Takenori Doumei; Yoichi Takaya; Nobuhiko Ohnishi; Atsushi Takaishi; Satoshi Hirohata; Toru Miyoshi; Ryoko Shinohata; Shinichi Usui; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

10.  Age-related differences in the distribution of peripheral atherosclerosis: when is atherosclerosis truly premature?

Authors:  M E Hansen; R J Valentine; D D McIntire; S I Myers; A Chervu; G P Clagett
Journal:  Surgery       Date:  1995-11       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.